Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell RNA-sequencing reveals cellular heterogeneity and immune microenvironment characteristics between ocular adnexal mucosa-associated lymphoid lymphoma and IgG4-related ophthalmic disease. | Front Immunol | 2025 | 40078987 | PubTator, text mining | PubMed |
| CD8α and CD70 mark human natural killer cell populations which differ in cytotoxicity. | Front Immunol | 2025 | 40046047 | PubTator, text mining | PubMed |
| Development and Preclinical Evaluation of [64Cu]Cu-NOTA-ABDB6: A CD70 and Albumin Dual-Binding Tracer with Improved Pharmacokinetics. | J Nucl Med | 2025 | 40015924 | PubTator, text mining | PubMed |
| Pt-Au Nanoparticles in Combination with Near-Infrared-Based Hyperthermia Increase the Temperature and Impact on the Viability and Immune Phenotype of Human Hepatocellular Carcinoma Cells. | Int J Mol Sci | 2025 | 40004038 | PubTator, text mining | PubMed |
Accelerating the clinical translation of CD70-targeted chimeric antigen receptor-based cell therapies in oncology: A comprehensive clinical investigation panorama analysis based on the Trialtrove database. | Cancer Lett | 2025 | 39922452 | PubTator, text mining | PubMed |
| Interrupting T cell memory ameliorates exaggerated metabolic response to weight cycling. | bioRxiv | 2025 | 39896598 | PubTator, text mining | PubMed |
| Revolutionizing acute myeloid leukemia treatment: a systematic review of immune-based therapies. | Discov Oncol | 2025 | 39864030 | PubTator, text mining | PubMed |
| CD70-targeted iPSC-derived CAR-NK cells display potent function against tumors and alloreactive T cells. | Cell Rep Med | 2025 | 39793572 | PubTator, text mining | PubMed |
| High-risk MCL: recognition and treatment. | Blood | 2025 | 39786418 | PubTator, text mining | PubMed |
| Diagnostic and predictive values of m5C‑associated genes in idiopathic pulmonary fibrosis. | Mol Med Rep | 2025 | 39704195 | PubTator, text mining | PubMed |
| If it is a solid tumor target, then it may be a hematologic cancer target: Bridging the great divide. | Med | 2025 | 39689708 | PubTator, text mining | PubMed |
Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): a single-arm, open-label, phase 1, dose-escalation study. | Lancet Oncol | 2025 | 39617017 | PubTator, text mining | PubMed |
| CD70 CAR T cells secreting an anti-CD33/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML. | Blood | 2025 | 39571145 | PubTator, text mining | PubMed |
| CD70: An Emerging Anticancer Target in Renal Cell Carcinoma and Beyond. | Annu Rev Med | 2025 | 39570653 | PubTator, text mining | PubMed |
| Molecular imaging of renal cell carcinomas: ready for prime time. | Nat Rev Urol | 2025 | 39543358 | PubTator, text mining | PubMed |
| Single-cell transcriptome analysis reveals atypical monocytes circulating ahead of acute graft-versus-host disease clinical onset. | J Leukoc Biol | 2025 | 39432735 | PubTator, text mining | PubMed |
| Benzoic acid, 4-hydroxy-, methyl ester from Smilax zeylanica Linn emerges as a potent inhibitor of CD27/CD70 signaling pathway. | J Biomol Struct Dyn | 2025 | 38353477 | PubTator, text mining | PubMed |
| A self-activated and protective module enhances the preclinical performance of allogeneic anti-CD70 CAR-T cells. | Front Immunol | 2024 | 39906740 | PubTator, text mining | PubMed |
| Generation and characterization of OX40-ligand fusion protein that agonizes OX40 on T-Lymphocytes. | Front Immunol | 2024 | 39867912 | PubTator, text mining | PubMed |
| Targeted Variant Assessments of Human Endogenous Retroviral Regions in Whole Genome Sequencing Data Reveal Retroviral Variants Associated with Papillary Thyroid Cancer. | Microorganisms | 2024 | 39770638 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=12